Clinical trial Recruiting at 1 site Observational Ages 18 to 50

Investigating how sex hormones affect gut microbiome and heart health in transgender individuals

Official title: Sex Hormone-specific Cardiovascular Risks in the Gut Microbiome-host Axis - A Longitudinal Cohort Study.

Run by Charite University, Berlin, Germany · NCT05334888 · Data updated 2026-11-12

This study tests how sex hormones affect gut health and heart risks in transgender individuals receiving hormone therapy.

More Gut Microbiome trials

Quick facts

Study typeObservational
Ages18 Years to 50 Years
SexAll
Enrollment200 (estimated)
SponsorCharite University, Berlin, Germany
Academic / other
Locations1 site (Berlin)
StatusRecruiting
StartedAugust 29, 2022
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedJune 15, 2026
Trial IDNCT05334888 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy transgender individuals aged 18-50 who are undergoing hormone replacement therapy.

Probably not a fit

Patients with significant health issues or those unable to understand the study's nature may not benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study examines the impact of sex hormones on the gut microbiome and the potential development of cardiovascular risk factors in transgender individuals undergoing hormone replacement therapy. Over two years, 200 healthy participants will be monitored for changes in their microbiome, metabolome, and immune system, while also assessing cardiovascular disease phenotypes. Utilizing advanced scientific methods, the study aims to quantify the influence of sex hormones on cardiovascular risk markers for the first time.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of cardiovascular risks in transgender individuals.

How similar studies have gone: While the approach is innovative, similar studies have not been extensively documented, making this a novel investigation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18-50
* Language requirements: German, English
* Previous gender hormone replacement therapy (HRT).
* Ability to give consent and written consent to participate.
* Health insurance (for clarification of incidental findings)

Exclusion Criteria:

* Diseases or functional disorders that, in the opinion of the study physician, preclude participation in the study.
* Incapacity or other circumstances that do not allow study participants to fully understand the nature, significance and scope of this study.

Where it's running

  • Experimental and Clinical Research Center, Clinical Research Unit
    Berlin, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.